Publication | Closed Access
Activation of KIF4A as a Prognostic Biomarker and Therapeutic Target for Lung Cancer
187
Citations
39
References
2007
Year
These data strongly implied that targeting the KIF4A molecule might hold a promise for the development of anticancer drugs and cancer vaccines as well as a prognostic biomarker in clinic.
| Year | Citations | |
|---|---|---|
Page 1
Page 1